Trials / Unknown
UnknownNCT02324127
Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,100 (estimated)
- Sponsor
- Protgen Ltd · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases.
Detailed description
Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases, validate accuracy, specificity and sensitivity of Hsp90α kit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hsp90 | Detect plasma Hsp90α concentration of lung cancer patients |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-12-24
- Last updated
- 2014-12-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02324127. Inclusion in this directory is not an endorsement.